Graph AI is a California-based AI life sciences startup founded in 2024 that develops AI-driven pharmacovigilance solutions to automate drug safety monitoring and improve patient safety. Its flagship product, Graph Safety Suite, is a SaaS platform that integrates fragmented workflows in pharmacovigilance, automating adverse drug event detection, case processing, signal detection, regulatory reporting, and compliance to enhance efficiency and accuracy for pharmaceutical companies.
1
Round
1
Industry
5
Tags
Sep 10, 2026
Latest raise
Funding activity · 1 round
Sep 10, 2026
$13.3M
Series A
Led by Insight Partners
Graph AI Closes $13.3M Series A Graph AI, a California based AI life sciences startup, has raised $13.3 million in Series A funding. The round was led by Insig…
Read articlePricing
Public hubs orient you on the raise. Paid plans unlock live AI adoption signals across your market.
For individuals and small teams getting started with AI buyer intelligence.
$149
/month
Features
For outbound teams and agencies that need more coverage and faster signal cadence.
$249
/month
Features
Act on this raise
Funding is the starting point. VeilStrat shows whether capital is showing up as hiring, tools, and web activity you can sell into.
